Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system. By working with our device customers to integrate technologies at the point of care, we are the partner of choice for improving patient and caregiver safety, clinical outcomes, cost management, as well as caregiver efficiency and effectiveness. Additionally, our One2One™ business is a leading provider of contract manufacturing services to proprietary pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals.
Parent Company
Lake Forest, US
Hospira is headquartered in Lake Forest, US

Hospira Office Locations

Hospira has an office in Lake Forest
Lake Forest, US (HQ)
275 N Field Dr

Hospira Financials and Metrics

Hospira Financials

USDFY, 2013FY, 2014


798.1 m802.4 m

Accounts Receivable

101.3 m117.3 m

Current Assets

2.8 b3 b


1.6 b1.8 b
USDFY, 2013FY, 2014

Net Income

(8.3 m)333.2 m

Depreciation and Amortization

171.8 m181.4 m


(140 m)(73 m)

Accounts Payable

41.3 m87.5 m
Show all financial metrics

Hospira Median Salaries

Source: 139 public H-1B filings from Hospira

Hospira's Web-traffic and Trends

Hospira News and Updates

Infusion Pumps Market is Poised to Reach US$ 4,922 Million by the End of 2025

The global infusion pumps market is estimated at US$ 4,922 Mn in 2025. The market is expected to expand at a CAGR of 5% over the forecast period, 2015–2025 Posted via Industry Today. Follow us on Twitter @IndustryToday

The World Pain management devices Market Will Expected reach $5.81 billion by 2023

Global pain management devices market research report, type (stimulators, transcutaneous electrical nerve stimulation devices, pumps, ablation devices), application (cancer pain, musculoskeletal pain, migraine and other) - Forecast Till 2023 Posted via Industry Today. Follow us on Twitter @IndustryT…

How smart pump EHR integration could save a community hospital $2 million

Beyond patient safety, the initiative has improved nurse workflow and is leading to more accurate billing, says CIO.

Hospira Company Life and Culture

You may also be interested in